[1] Meyers RL,Czauderna P,Otte JB. Surgical treatment of hepatoblastoma. Pediatr Blood Cancer,2012,59（5）：800-808.
[2] Ismail H,Broniszczak D,Kaliciński P,et al.Changing treatment and outcome of children with hepatoblastoma: analysis of a single center experience over the last 20 years.J Pediatr Surg,2012,47（7）：1331-1339.
[3] 张伟令,张谊,黄东生,等. 儿童晚期肝母细胞瘤综合治疗的疗效观察. 中华实用儿科临床杂志,2013,28（7）：521-524.
[4] Gupta K,Rane S,Das A,et al. Relationship of beta-catenin and postchemotherapy histopathologic changes with overall survival in patients with hepatoblastoma. J Pediatr Hematol Oncol,2012,34（8）：320-328.
[5] 胡亚美,江载芳.诸福棠实用儿科学. 7版,北京：人民卫生出版社,2002：16-42.
[6] Zsiros J,Brugieres L,Brock P,et al. Dose-dense cisplatin-based chemotherapy and surgery for children with high risk hepatoblastoma （SIOPEL4）：a prospective,single-arm,feasibility study. Lancet Oncol,2013,14（9）：834-842.
[7] Tsay PK,Lai PK,Yang CP,et al.Treatment outcomes for hepatoblastoma：Experience of 35 cases at a single institution.J Formos Med Assoc,2011,110（5）：322-325.
[8] Arora RS.Outcomes of hepatoblastoma in the Indian context.Indian Pediatrics,2012,49（4）：307-309.
[9] Barrena S,Hernandez F,Miguel M,et al.High-risk hepatoblastoma：results in a pediatric liver transplantation center.Eur J Pediatr Surg,2011,21（1）：18-20.
[10] Sail MW,Li J,Lamb L,et al. First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second- line therapy in patients with advanced pancreatic cancer. Cancer Chemother Pharmacol,2014,73（2）：373-380.
[11] Karski EE,Dvorak CC,Leung W,et al. Treatment of hepatoblastoma with high-dose chemotherapy and stem cell rescue:the pediatric blood and marrow transplant consortium experience and review of the literature.J Pediatr Hematol Oncol,2014,36（5）：362-368.
[12] Malogolowkin MH,Katzenstein HM,Meyers RL,et al. Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology:a report from the Children's Oncology Group. J Clin Oncol,2011,29（24）：3301-3306.
[13] Von Schweinitz D.Hepatoblastoma:recent developments in research and treatment.Semin Pediatr Surg,2012,21（1）：21-30.
[14] Maibach R,Roebuck D,Brugieres L,et al. Prognostic stratification for children with hepatoblastoma:the SIOPEL experience.Eur J Cancer,2012,48（10）：1543-1549.
[15] Ueda Y,Hiyama E,Kamimatsuse A,et al.Wnt signaling and telomerase activation of hepatoblastoma:correlation with chemosensitivity and surgical respectability. J Pediatr Surg,2011,46（12）：2221-2227.
[16] 乔晓红,赵强,胡月,等. 儿童肝母细胞瘤综合治疗27例疗效探讨. 中华小儿外科杂志,2012,33（9）：647-650.
[17] 李丹妮,于新生,赵爱芝,等.影响儿童肝母细胞瘤预后的多因素分析. 中国实用儿科杂志,2013,28（2）：126-128.
[18] Koh KN,Park M,Kim BE,et al. Prognostic implications of serum alpha-fetoprotein response during treatment of hepatoblastoma.Pediatr Blood Cancer,2011,57（4）：554-560.
[19] 吴艳梅,王珊,胡显良,等. 术前应用经导管动脉化疗栓塞治疗儿童肝母细胞瘤的疗效分析. 重庆医科大学学报,2014,39（2）：241-245.
[20] 葛军涛,李龙,乔国梁,等. 肝母细胞瘤预后评分系统的建立并比较其与常见预后模型的预测价值.中华小儿外科杂志,2015,36（1）：21-25. |
